TherapeuticsMD (TXMD) Depreciation & Amortization - Total (2011 - 2023)
TherapeuticsMD (TXMD) reported Depreciation & Amortization - Total of $100000.0 for Q4 2023, down 50.0% on a YoY basis from $200000.0 in Q4 2022, and down 23.08% quarter-over-quarter from $130000.0 in Q3 2023.
TherapeuticsMD (TXMD) Depreciation & Amortization - Total (2011 - 2023) Analysis & Trends
TherapeuticsMD has reported Depreciation & Amortization - Total for 7 years, with the latest figure at $100000.0 in Q4 2023.
- For the quarter ending Q4 2023, Depreciation & Amortization - Total fell 50.0% year-over-year to $100000.0; the trailing twelve-month figure through Sep 2024 stood at $100000.0 (down 71.99% YoY), and the FY2023 full-year result was $100000.0, down 83.33% from the prior year.
- Depreciation & Amortization - Total for Q4 2023 stood at $100000.0, down from $130000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $329000.0 in Q1 2022, with the low at $27000.0 in Q1 2023.
- Historically, Depreciation & Amortization - Total has averaged $166819.5 across 3 years, with a median of $165000.0 in 2022.
- Annual changes were most pronounced in 2019 — Depreciation & Amortization - Total surged 63.22% — and 2023, when it sank 91.79%.
- TherapeuticsMD's Depreciation & Amortization - Total stood at $66556.0 in 2019, then soared by 200.5% to $200000.0 in 2022, then slumped by 50.0% to $100000.0 in 2023.
- The last three Depreciation & Amortization - Total figures came in at $100000.0 (Q4 2023), $130000.0 (Q3 2023), and $27000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 130,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 282,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Jun 30, 2019 | 66,556.00 |
| Jun 30, 2018 | 40,777.00 |
| Mar 31, 2013 | 4,703.00 |
| Dec 31, 2012 | -16,468.00 |
| Sep 30, 2012 | 14,839.00 |
| Jun 30, 2012 | 22,105.00 |
| Mar 31, 2012 | 7,008.00 |
| Dec 31, 2011 | -15,447.00 |
| Sep 30, 2011 | 13,711.00 |